Monday, 21 Oct 2019

You are here

Respiratory Risks Not Increased in RA Patients with COPD

An insurance claims based study of rheumatoid arthritis (RA) patients with chronic obstructive pulmonary disease (COPD) shows that biologics do not have an increased rate of respiratory events compared to those on conventional DMARDs.

A real world cohort of RA patients with COPD was drawn from US-based MarketScan databases. Patients on biologic DMARDs and/or targeted synthetic DMARDs (tsDMARDs) were propensity matched to those on conventional synthetic DMARDs (csDMARDs).

The study compared 7424 RA/COPD patients initiating biologic/tsDMARDs to 7424 patients initiating csDMARDs.

Comparing biologic/tsDMARD vs csDMARD shows the adjusted hazard ratio for:

  • hospitalized COPD exacerbation = 0.76 (95% CI: 0.55, 1.06)
  • bronchitis = HR 1.02 (95% CI: 0.82, 1.27)
  • hospitalized pneumonia or influenza = 1.21 (95% CI: 0.92, 1.58)
  • outpatient pneumonia or influenza=  0.99 (95% CI: 0.87, 1.12)

The hazard ratio of the combined end point of COPD exacerbation, bronchitis and hospitalized pneumonia or influenza was 1.04 (95% CI: 0.89, 1.21).

Biologic and tsDMARDs appear to be safe to use in RA patients with COPD, having a low risk of adverse respiratory events.

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

Stress and the Risk of Incident Inflammatory Arthritis

A prospective analysis of newly diagnosed, inflammatory arthritis (IA) patients suggests that perceived distress (stress) increases the odds of incident IA.

Juvenile Arthritis at Risk for Coronary Artery Disease

Arthritis Care & Research reports that juvenile arthritis (JA) patients may have a higher risk if coronary artery disease (CAD) in adulthood. 

Data was drawn from the National Health and Nutrition Examination (2007‐2014).  The diagnoses of JA and CAD were self declared by respondents.

Long Delays for Inflammatory Arthritis Patients

The National Rheumatoid Arthritis Society's (NRAS) annual audit has identified significant treatment delays for patients with suspected early inflammatory arthritis could result in unnecessary harm. 

Antibiotics Increase Rheumatoid Risk - Again

Another UK study has suggested that prior use of antibiotics increases the risk of developing rheumatoid arthritis (RA).

Rheumatology has published a 15 year case–control study that compared 8482 newly diagnosed RA patients and 22,661 controls from the UK’s Royal College of General Practitioners Research and Surveillance Centre database (between 2006 and 2018).

Two vs. Four Weeks of Antibiotic Therapy in Septic Arthritis

A prospective trial has shown that 2 weeks of antibiotic therapy is as effective as 4 weeks of antibiotic therapy, with similar outcomes but shorter hospital stays.

This Swiss study was a prospective, unblinded, randomised, non-inferiority study comparing either 2 or 4 weeks of antibiotic therapy after surgical drainage of native joint bacterial arthritis in adults.